Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total debt
Total debt on the balance sheet as of December 2023 : $41.52 M
According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is $41.52 M. A company’s total debt is the sum of all current and non-current debts.
Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $41.52 M | -90.66% |
| 2022-12-31 | $0.44 B | 4.15% |
| 2021-12-31 | $0.42 B | 3.07% |
| 2020-12-31 | $0.41 B | 9.48% |
| 2019-12-31 | $0.37 B | 14.86% |
| 2018-12-31 | $0.32 B | |
| 2017-12-31 | $N/A | -100% |
| 2016-12-31 | $4.16 M | -41.21% |
| 2015-12-31 | $7.08 M | -72.98% |
| 2014-12-31 | $26.22 M | -23.75% |
| 2013-12-31 | $34.39 M | 50.21% |
| 2012-12-31 | $22.89 M | -22.35% |
| 2011-12-31 | $29.48 M | -60.69% |
| 2010-12-31 | $75 M | 0% |
| 2009-12-31 | $75 M | 0% |
| 2008-12-31 | $75 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 70,533.56% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 37,533.35% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 60,644.34% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 138,145.00% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 United Therapeutics UTHR | $0.70 B | 1,585.65% | 🇺🇸 USA |